Change language
English Deutsch
Change currency
€ EUR £ GBP $ USD
Publicly Available Published by De Gruyter June 9, 2020

Frontmatter

From the journal Clinical Chemistry and Laboratory Medicine (CCLM)
https://doi.org/10.1515/cclm-2020-frontmatter7
Download article (PDF)
Published Online: 2020-06-09
Published in Print: 2020-06-25

©2020 Walter de Gruyter GmbH, Berlin/Boston

Download article (PDF)
From the journal
Clinical Chemistry and Laboratory Medicine (CCLM)
Clinical Chemistry and Laboratory Medicine (CCLM)
Volume 58 Issue 7

Journal and Issue

Articles in the same Issue

Frontmatter
Editorial
Critical role of laboratory medicine in the global response to the COVID-19 pandemic
Reviews
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
COVID-19: progression of disease and intravascular coagulation – present status and future perspectives
IFCC Recommendations
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence
Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations
Opinion Papers
The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks
Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)
Laboratory diagnostics within a modular hospital at the time of Coronavirus disease 2019 (COVID-19) in Wuhan
Original Articles
Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics
Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2)-infected pneumonia (COVID-19)
Routine blood tests as a potential diagnostic tool for COVID-19
Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy
The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
The value of urine biochemical parameters in the prediction of the severity of coronavirus disease 2019
Letters to the Editor
COVID-19 infections are also affected by human ACE1 D/I polymorphism
No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection
ACE Ins/Del genetic polymorphism and epidemiological findings in COVID-19
Laboratory abnormalities in patients with COVID-2019 infection
Laboratory abnormalities in children with novel coronavirus disease 2019
Clinical laboratory and SARS-CoV-2 infection: where do we stand?
Clinical chemistry tests for patients with COVID-19 – important caveats for interpretation
Antibody tests for COVID-19: drawing attention to the importance of analytical specificity
Erythrocyte sedimentation rate is associated with severe coronavirus disease 2019 (COVID-19): a pooled analysis
One disease, different features: COVID-19 laboratory and radiological findings in three Italian patients
Decreased “WBC*LYM” was observed in SARS-CoV-2-infected patients from a fever clinic in Wuhan
Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays
Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children
The friendly use of chloroquine in the COVID-19 disease: a warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene
Potential interference of hydroxychloroquine-glucuronide metabolite on therapeutic drug monitoring of hydroxychloroquine using a mass spectrometry detector
Downloaded on 7.12.2023 from https://www.degruyter.com/document/doi/10.1515/cclm-2020-frontmatter7/html
Scroll to top button